Clinical trial
Secondary Prevention With Long-term Oral Esomeprazole for Peptic Ulcer Recurrence and Rebleeding in High-risk Rockall Scores ≥ 6 Patients
NCT02456012 is registered in ClinicalTrials.gov with Hsiu-Chi Cheng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Secondary Prevention With Long-term Oral Esomeprazole for Peptic Ulcer Recurrence and Rebleeding in High-risk Rockall Scores ≥ 6 Patients
- Lead sponsor
- Hsiu-Chi Cheng
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- December 31, 2020
- Enrollment
- 268 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.